Phenotype
|
Fish
|
Conditions
|
Figures
|
hatching decreased occurrence, abnormal
|
cox17hza2/hza2
|
chemical treatment by environment: copper(2+)
|
Fig. 6
from Zhang et al., 2018
|
hatching decreased occurrence, abnormal
|
cox17hza2/hza2
|
chemical treatment by environment: copper atom
|
Fig. 6
from Zhang et al., 2018
|
whole organism eaf1 expression decreased amount, abnormal
|
cox17hza2/hza2 (AB)
|
standard conditions
|
Fig. 3
from Sun et al., 2019
|
swim bladder mesenchyme acta2 expression amount, ameliorated
|
cox17hza2/hza2 (AB)
|
chemical treatment by environment: copper(2+)
|
Fig. 7
from Sun et al., 2019
|
whole organism reactive oxygen species amount, abnormal
|
cox17hza2/hza2 (AB)
|
chemical treatment by environment: copper(2+)
|
Fig. 5
from Sun et al., 2019
|
whole organism sox2 expression amount, ameliorated
|
cox17hza2/hza2 (AB)
|
chemical treatment by environment: copper(2+)
|
Fig. 7
from Sun et al., 2019
|
whole organism anxa5b expression decreased amount, abnormal
|
cox17hza2/hza2 (AB)
|
standard conditions
|
Fig. 7
from Sun et al., 2019
|
whole organism fgf10a expression increased amount, abnormal
|
cox17hza2/hza2 (AB)
|
standard conditions
|
Fig. 7
from Sun et al., 2019
|
whole organism mnx1 expression amount, ameliorated
|
cox17hza2/hza2 (AB)
|
chemical treatment by environment: copper(2+)
|
Fig. 7
from Sun et al., 2019
|
whole organism mnx1 expression decreased amount, abnormal
|
cox17hza2/hza2 (AB)
|
standard conditions
|
Fig. 7
from Sun et al., 2019
|
whole organism mt2 expression decreased amount, abnormal
|
cox17hza2/hza2 (AB)
|
standard conditions
|
Fig. 3
from Sun et al., 2019
|
swim bladder bud pbx1a expression decreased amount, abnormal
|
cox17hza2/hza2 (AB)
|
chemical treatment by environment: copper(2+)
|
Fig. 7
from Sun et al., 2019
|
whole organism acta2 expression amount, ameliorated
|
cox17hza2/hza2 (AB)
|
chemical treatment by environment: copper(2+)
|
Fig. 7
from Sun et al., 2019
|
stress response to copper ion arrested, abnormal
|
cox17hza2/hza2 (AB)
|
chemical treatment by environment: copper(2+)
|
Fig. 5
from Sun et al., 2019
|
whole organism vps51 expression decreased amount, abnormal
|
cox17hza2/hza2 (AB)
|
standard conditions
|
Fig. 3
from Sun et al., 2019
|
whole organism fgf10a expression increased amount, abnormal
|
cox17hza2/hza2 (AB)
|
chemical treatment by environment: copper(2+)
|
Fig. 7
from Sun et al., 2019
|
swim bladder mesenchyme acta2 expression increased amount, abnormal
|
cox17hza2/hza2 (AB)
|
standard conditions
|
Fig. 7
from Sun et al., 2019
|
whole organism mnx1 expression increased amount, abnormal
|
cox17hza2/hza2 (AB)
|
standard conditions
|
Fig. 7
from Sun et al., 2019
|
whole organism axin2 expression decreased amount, abnormal
|
cox17hza2/hza2 (AB)
|
standard conditions
|
Fig. 4
from Sun et al., 2019
|
whole organism sco1 expression decreased amount, abnormal
|
cox17hza2/hza2 (AB)
|
standard conditions
|
Fig. 3
from Sun et al., 2019
|
whole organism wnt7ba expression decreased amount, abnormal
|
cox17hza2/hza2 (AB)
|
standard conditions
|
Fig. 4
from Sun et al., 2019
|
hemoglobin biosynthetic process occurrence, abnormal
|
cox17hza2/hza2 (AB)
|
chemical treatment by environment: copper(2+)
|
Fig. 5
from Sun et al., 2019
|
whole organism mnx1 expression decreased amount, abnormal
|
cox17hza2/hza2 (AB)
|
chemical treatment by environment: copper(2+)
|
Fig. 7
from Sun et al., 2019
|
whole organism rad51 expression decreased amount, abnormal
|
cox17hza2/hza2 (AB)
|
standard conditions
|
Fig. 3
from Sun et al., 2019
|
whole organism anxa5b expression decreased amount, abnormal
|
cox17hza2/hza2 (AB)
|
chemical treatment by environment: copper(2+)
|
Fig. 7
from Sun et al., 2019
|
swim bladder mesothelial cell anxa5b expression decreased amount, abnormal
|
cox17hza2/hza2 (AB)
|
standard conditions
|
Fig. 7
from Sun et al., 2019
|
whole organism sox2 expression increased amount, abnormal
|
cox17hza2/hza2 (AB)
|
standard conditions
|
Fig. 7
from Sun et al., 2019
|
whole organism pbx1a expression amount, ameliorated
|
cox17hza2/hza2 (AB)
|
chemical treatment by environment: copper(2+)
|
Fig. 7
from Sun et al., 2019
|
whole organism hprt1l expression decreased amount, abnormal
|
cox17hza2/hza2 (AB)
|
chemical treatment by environment: copper(2+)
|
Fig. 7
from Sun et al., 2019
|
whole organism hprt1l expression decreased amount, abnormal
|
cox17hza2/hza2 (AB)
|
standard conditions
|
Fig. 7
from Sun et al., 2019
|
whole organism pbx1a expression increased amount, abnormal
|
cox17hza2/hza2 (AB)
|
standard conditions
|
Fig. 7
from Sun et al., 2019
|
swim bladder mesothelial cell anxa5b expression decreased amount, abnormal
|
cox17hza2/hza2 (AB)
|
chemical treatment by environment: copper(2+)
|
Fig. 7
from Sun et al., 2019
|
whole organism tert expression increased amount, abnormal
|
cox17hza2/hza2 (AB)
|
standard conditions
|
Fig. 3
from Sun et al., 2019
|
whole organism acta2 expression increased amount, abnormal
|
cox17hza2/hza2 (AB)
|
standard conditions
|
Fig. 7
from Sun et al., 2019
|
whole organism sfrp1b expression decreased amount, abnormal
|
cox17hza2/hza2 (AB)
|
standard conditions
|
Fig. 4
from Sun et al., 2019
|
whole organism wnt3 expression decreased amount, abnormal
|
cox17hza2/hza2 (AB)
|
standard conditions
|
Fig. 4
from Sun et al., 2019
|
central nervous system pou3f1 expression decreased amount, abnormal
|
cox17hza3/hza3
|
chemical treatment by environment: copper(2+)
|
Fig. 7
from Zhang et al., 2020
|
intestinal epithelial cell mitochondrial inner membrane swollen, abnormal
|
cox17hza3/hza3
|
control
|
Fig. 5
from Zhao et al., 2019
|
whole organism hspa5 expression increased amount, abnormal
|
cox17hza3/hza3
|
chemical treatment: copper atom
|
Fig. 5
from Zhao et al., 2019
|
intestine slc15a1b expression decreased amount, abnormal
|
cox17hza3/hza3
|
control
|
Fig. 5
from Zhao et al., 2019
|
retina opn1sw1 expression decreased amount, abnormal
|
cox17hza3/hza3
|
chemical treatment: copper atom
|
Fig. 6
from Zhao et al., 2020
|
whole organism opn1lw1 expression decreased amount, abnormal
|
cox17hza3/hza3
|
chemical treatment: copper(2+)
|
Fig. 6
from Zhao et al., 2020
|
retina opn1lw1 expression decreased amount, abnormal
|
cox17hza3/hza3
|
chemical treatment: copper(2+)
|
Fig. 6
from Zhao et al., 2020
|
whole organism cyp3a65 expression decreased amount, abnormal
|
cox17hza3/hza3
|
chemical treatment: copper atom
|
Fig. 5
from Zhao et al., 2019
|
whole organism slc15a1b expression decreased amount, abnormal
|
cox17hza3/hza3
|
control
|
Fig. 5
from Zhao et al., 2019
|
whole organism opn1sw1 expression decreased amount, abnormal
|
cox17hza3/hza3
|
chemical treatment: copper atom
|
Fig. 6
from Zhao et al., 2020
|
whole organism eif2ak3 expression increased amount, abnormal
|
cox17hza3/hza3
|
chemical treatment: copper(2+)
|
Fig. 6
from Zhao et al., 2020
|
whole organism slc15a1b expression decreased amount, abnormal
|
cox17hza3/hza3
|
chemical treatment: copper atom
|
Fig. 5
from Zhao et al., 2019
|
retina opn1lw1 expression decreased amount, abnormal
|
cox17hza3/hza3
|
chemical treatment: copper atom
|
Fig. 6
from Zhao et al., 2020
|
retina mitochondrion swollen, abnormal
|
cox17hza3/hza3
|
chemical treatment: copper atom
|
Fig. 6
from Zhao et al., 2020
|
whole organism cox4i2 expression decreased amount, abnormal
|
cox17hza3/hza3
|
chemical treatment: copper atom
|
Fig. 6
from Zhao et al., 2020
|
intestinal epithelial cell endoplasmic reticulum structure, exacerbated
|
cox17hza3/hza3
|
chemical treatment: copper atom
|
Fig. 5
from Zhao et al., 2019
|
whole organism loxa expression decreased amount, abnormal
|
cox17hza3/hza3
|
chemical treatment: copper atom
|
Fig. 6
from Zhao et al., 2020
|
intestinal epithelial cell mitochondrial inner membrane swollen, exacerbated
|
cox17hza3/hza3
|
chemical treatment: copper(2+)
|
Fig. 5
from Zhao et al., 2019
|
central nervous system pou3f1 expression decreased amount, abnormal
|
cox17hza3/hza3
|
standard conditions
|
Fig. 7
from Zhang et al., 2020
|
whole organism cox4i2 expression decreased amount, abnormal
|
cox17hza3/hza3
|
chemical treatment: copper(2+)
|
Fig. 6
from Zhao et al., 2020
|
retina mitochondrion swollen, abnormal
|
cox17hza3/hza3
|
chemical treatment: copper(2+)
|
Fig. 6
from Zhao et al., 2020
|
whole organism opn1lw1 expression decreased amount, abnormal
|
cox17hza3/hza3
|
chemical treatment: copper atom
|
Fig. 6
from Zhao et al., 2020
|
whole organism fabp2 expression decreased amount, abnormal
|
cox17hza3/hza3
|
chemical treatment: copper atom
|
Fig. 5
from Zhao et al., 2019
|
whole organism atf6 expression increased amount, abnormal
|
cox17hza3/hza3
|
chemical treatment: copper atom
|
Fig. 6
from Zhao et al., 2020
|
whole organism loxa expression decreased amount, abnormal
|
cox17hza3/hza3
|
chemical treatment: copper(2+)
|
Fig. 6
from Zhao et al., 2020
|
whole organism cyp8b1.1 expression decreased amount, abnormal
|
cox17hza3/hza3
|
chemical treatment: copper atom
|
Fig. 5
from Zhao et al., 2019
|
whole organism atf6 expression increased amount, abnormal
|
cox17hza3/hza3
|
chemical treatment: copper(2+)
|
Fig. 6
from Zhao et al., 2020
|
retina opn1sw1 expression decreased amount, abnormal
|
cox17hza3/hza3
|
chemical treatment: copper(2+)
|
Fig. 6
from Zhao et al., 2020
|
intestine fabp2 expression decreased amount, abnormal
|
cox17hza3/hza3
|
chemical treatment: copper atom
|
Fig. 5
from Zhao et al., 2019
|
whole organism opn1lw1 expression decreased amount, abnormal
|
cox17hza3/hza3
|
control
|
Fig. 6
from Zhao et al., 2020
|
whole organism rho expression decreased amount, abnormal
|
cox17hza3/hza3
|
chemical treatment: copper(2+)
|
Fig. 6
from Zhao et al., 2020
|
retina opn1sw1 expression decreased amount, abnormal
|
cox17hza3/hza3
|
control
|
Fig. 6
from Zhao et al., 2020
|
intestine fabp2 expression decreased amount, abnormal
|
cox17hza3/hza3
|
control
|
Fig. 5
from Zhao et al., 2019
|
retina opn1lw1 expression decreased amount, abnormal
|
cox17hza3/hza3
|
control
|
Fig. 6
from Zhao et al., 2020
|
whole organism opn1sw1 expression decreased amount, abnormal
|
cox17hza3/hza3
|
chemical treatment: copper(2+)
|
Fig. 6
from Zhao et al., 2020
|
whole organism opn1sw1 expression decreased amount, abnormal
|
cox17hza3/hza3
|
control
|
Fig. 6
from Zhao et al., 2020
|
whole organism eif2ak3 expression increased amount, abnormal
|
cox17hza3/hza3
|
chemical treatment: copper atom
|
Fig. 6
from Zhao et al., 2020
|
intestinal epithelial cell endoplasmic reticulum structure, exacerbated
|
cox17hza3/hza3
|
chemical treatment: copper(2+)
|
Fig. 5
from Zhao et al., 2019
|
whole organism rho expression decreased amount, abnormal
|
cox17hza3/hza3
|
chemical treatment: copper atom
|
Fig. 6
from Zhao et al., 2020
|
whole organism ern1 expression increased amount, abnormal
|
cox17hza3/hza3
|
chemical treatment: copper(2+)
|
Fig. 6
from Zhao et al., 2020
|
whole organism cyp3a65 expression decreased amount, abnormal
|
cox17hza3/hza3
|
control
|
Fig. 5
from Zhao et al., 2019
|
central nervous system mbpa expression decreased amount, abnormal
|
cox17hza3/hza3
|
chemical treatment by environment: copper(2+)
|
Fig. 7
from Zhang et al., 2020
|
whole organism znrf2a expression decreased amount, abnormal
|
cox17hza3/hza3
|
chemical treatment: copper atom
|
Fig. 6
from Zhao et al., 2020
|
whole organism rho expression decreased amount, abnormal
|
cox17hza3/hza3
|
control
|
Fig. 6
from Zhao et al., 2020
|
intestinal epithelial cell mitochondrial inner membrane swollen, exacerbated
|
cox17hza3/hza3
|
chemical treatment: copper atom
|
Fig. 5
from Zhao et al., 2019
|
whole organism ern1 expression increased amount, abnormal
|
cox17hza3/hza3
|
chemical treatment: copper atom
|
Fig. 6
from Zhao et al., 2020
|
whole organism hspa5 expression decreased amount, abnormal
|
cox17hza3/hza3
|
control
|
Fig. 5
from Zhao et al., 2019
|
intestinal epithelial cell endoplasmic reticulum loose, abnormal
|
cox17hza3/hza3
|
control
|
Fig. 5
from Zhao et al., 2019
|
whole organism znrf2a expression decreased amount, abnormal
|
cox17hza3/hza3
|
chemical treatment: copper(2+)
|
Fig. 6
from Zhao et al., 2020
|
intestine slc15a1b expression decreased amount, abnormal
|
cox17hza3/hza3
|
chemical treatment: copper atom
|
Fig. 5
from Zhao et al., 2019
|
whole organism cox17 expression decreased amount, abnormal
|
cox17hza3/hza3 (AB)
|
standard conditions
|
Fig. 1,
Fig. 2
from Sun et al., 2019
|
whole organism eaf1 expression decreased amount, abnormal
|
cox17hza3/hza3 (AB)
|
standard conditions
|
Fig. 3
from Sun et al., 2019
|
swim bladder mesenchyme acta2 expression amount, ameliorated
|
cox17hza3/hza3 (AB)
|
chemical treatment by environment: copper(2+)
|
Fig. 6
from Sun et al., 2019
|
whole organism sox2 expression amount, ameliorated
|
cox17hza3/hza3 (AB)
|
chemical treatment by environment: copper(2+)
|
Fig. 6
from Sun et al., 2019
|
whole organism anxa5b expression decreased amount, abnormal
|
cox17hza3/hza3 (AB)
|
standard conditions
|
Fig. 6
from Sun et al., 2019
|
whole organism fgf10a expression increased amount, abnormal
|
cox17hza3/hza3 (AB)
|
standard conditions
|
Fig. 6
from Sun et al., 2019
|
whole organism reactive oxygen species amount, abnormal
|
cox17hza3/hza3 (AB)
|
chemical treatment by environment: copper(2+)
|
Fig. 5
from Sun et al., 2019
|
whole organism mnx1 expression amount, ameliorated
|
cox17hza3/hza3 (AB)
|
chemical treatment by environment: copper(2+)
|
Fig. 6
from Sun et al., 2019
|
developmental growth delayed, abnormal
|
cox17hza3/hza3 (AB)
|
standard conditions
|
Fig. 1
from Sun et al., 2019
|
whole organism mnx1 expression decreased amount, abnormal
|
cox17hza3/hza3 (AB)
|
standard conditions
|
Fig. 6
from Sun et al., 2019
|
whole organism apoob expression decreased amount, abnormal
|
cox17hza3/hza3 (AB)
|
standard conditions
|
Fig. 2
from Sun et al., 2019
|
whole organism mt2 expression decreased amount, abnormal
|
cox17hza3/hza3 (AB)
|
standard conditions
|
Fig. 3
from Sun et al., 2019
|
whole organism acta2 expression amount, ameliorated
|
cox17hza3/hza3 (AB)
|
chemical treatment by environment: copper(2+)
|
Fig. 6
from Sun et al., 2019
|
swim bladder bud pbx1a expression decreased amount, abnormal
|
cox17hza3/hza3 (AB)
|
chemical treatment by environment: copper(2+)
|
Fig. 6
from Sun et al., 2019
|
whole organism vps51 expression decreased amount, abnormal
|
cox17hza3/hza3 (AB)
|
standard conditions
|
Fig. 3
from Sun et al., 2019
|
stress response to copper ion arrested, abnormal
|
cox17hza3/hza3 (AB)
|
chemical treatment by environment: copper(2+)
|
Fig. 5
from Sun et al., 2019
|
whole organism mnx1 expression increased amount, abnormal
|
cox17hza3/hza3 (AB)
|
standard conditions
|
Fig. 6
from Sun et al., 2019
|
swim bladder mesenchyme acta2 expression increased amount, abnormal
|
cox17hza3/hza3 (AB)
|
standard conditions
|
Fig. 6
from Sun et al., 2019
|
whole organism axin2 expression decreased amount, abnormal
|
cox17hza3/hza3 (AB)
|
standard conditions
|
Fig. 4
from Sun et al., 2019
|
whole organism sco1 expression decreased amount, abnormal
|
cox17hza3/hza3 (AB)
|
standard conditions
|
Fig. 3
from Sun et al., 2019
|
whole organism wnt7ba expression decreased amount, abnormal
|
cox17hza3/hza3 (AB)
|
standard conditions
|
Fig. 4
from Sun et al., 2019
|
hemoglobin biosynthetic process occurrence, abnormal
|
cox17hza3/hza3 (AB)
|
chemical treatment by environment: copper(2+)
|
Fig. 5
from Sun et al., 2019
|
whole organism rad51 expression decreased amount, abnormal
|
cox17hza3/hza3 (AB)
|
standard conditions
|
Fig. 3
from Sun et al., 2019
|
whole organism mnx1 expression decreased amount, abnormal
|
cox17hza3/hza3 (AB)
|
chemical treatment by environment: copper(2+)
|
Fig. 6
from Sun et al., 2019
|
whole organism anxa5b expression decreased amount, abnormal
|
cox17hza3/hza3 (AB)
|
chemical treatment by environment: copper(2+)
|
Fig. 6
from Sun et al., 2019
|
swim bladder mesothelial cell anxa5b expression decreased amount, abnormal
|
cox17hza3/hza3 (AB)
|
standard conditions
|
Fig. 6
from Sun et al., 2019
|
whole organism sox2 expression increased amount, abnormal
|
cox17hza3/hza3 (AB)
|
standard conditions
|
Fig. 6
from Sun et al., 2019
|
whole organism zgc:152891 expression decreased amount, abnormal
|
cox17hza3/hza3 (AB)
|
standard conditions
|
Fig. 2
from Sun et al., 2019
|
whole organism fgf10a expression amount, ameliorated
|
cox17hza3/hza3 (AB)
|
chemical treatment by environment: copper(2+)
|
Fig. 6
from Sun et al., 2019
|
whole organism pbx1a expression amount, ameliorated
|
cox17hza3/hza3 (AB)
|
chemical treatment by environment: copper(2+)
|
Fig. 6
from Sun et al., 2019
|
whole organism ruvbl2 expression decreased amount, abnormal
|
cox17hza3/hza3 (AB)
|
standard conditions
|
Fig. 2
from Sun et al., 2019
|
whole organism hprt1l expression decreased amount, abnormal
|
cox17hza3/hza3 (AB)
|
chemical treatment by environment: copper(2+)
|
Fig. 6
from Sun et al., 2019
|
whole organism hprt1l expression decreased amount, abnormal
|
cox17hza3/hza3 (AB)
|
standard conditions
|
Fig. 6
from Sun et al., 2019
|
whole organism pbx1a expression increased amount, abnormal
|
cox17hza3/hza3 (AB)
|
standard conditions
|
Fig. 6
from Sun et al., 2019
|
swim bladder mesothelial cell anxa5b expression decreased amount, abnormal
|
cox17hza3/hza3 (AB)
|
chemical treatment by environment: copper(2+)
|
Fig. 6
from Sun et al., 2019
|
whole organism tert expression increased amount, abnormal
|
cox17hza3/hza3 (AB)
|
standard conditions
|
Fig. 3
from Sun et al., 2019
|
whole organism sfrp1b expression decreased amount, abnormal
|
cox17hza3/hza3 (AB)
|
standard conditions
|
Fig. 4
from Sun et al., 2019
|
whole organism acta2 expression increased amount, abnormal
|
cox17hza3/hza3 (AB)
|
standard conditions
|
Fig. 6
from Sun et al., 2019
|
whole organism apool expression decreased amount, abnormal
|
cox17hza3/hza3 (AB)
|
standard conditions
|
Fig. 2
from Sun et al., 2019
|
whole organism wnt3 expression decreased amount, abnormal
|
cox17hza3/hza3 (AB)
|
standard conditions
|
Fig. 4
from Sun et al., 2019
|